Published in Yonsei Med J on March 01, 2014
Erythropoietic potential of CD34+ hematopoietic stem cells from human cord blood and G-CSF-mobilized peripheral blood. Biomed Res Int (2014) 0.78
Effect of Induced Pluripotent Stem Cell Technology in Blood Banking. Stem Cells Transl Med (2016) 0.75
Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility. Clin Med Insights Blood Disord (2016) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol (1993) 6.33
Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2001) 4.07
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol (2004) 3.76
Proof of principle for transfusion of in vitro-generated red blood cells. Blood (2011) 3.01
Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01
Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol (2002) 2.03
Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica (2010) 1.79
Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A (2008) 1.75
Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life (2009) 1.61
Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol (2006) 1.58
The aging population poses a global challenge for blood services. Transfusion (2009) 1.34
Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol (2011) 1.30
How much blood is needed? Vox Sang (2011) 1.30
Stem cells: roadmap to the clinic. J Clin Invest (2010) 1.27
Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev (2011) 1.17
Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc alpha 1----2Gal alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA. J Biol Chem (1990) 1.15
Ex vivo generation of human red blood cells: a new advance in stem cell engineering. Methods Mol Biol (2009) 1.11
Blood cell manufacture: current methods and future challenges. Trends Biotechnol (2009) 1.03
In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion (2008) 0.98
Prospects for the manufacture of red cells for transfusion. Br J Haematol (2010) 0.97
Autonomous control of terminal erythropoiesis via physical interactions among erythroid cells. Stem Cell Res (2013) 0.89
Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer. Transfusion (2009) 0.88
The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J Biotechnol (2009) 0.85
Red blood cell engineering in stroma and serum/plasma-free conditions and long term storage. Tissue Eng Part A (2011) 0.85
The history of blood transfusion. Br J Haematol (2000) 0.84
Enhanced production of red blood cells in suspension by electrostatic interactions with culture plates. Tissue Eng Part C Methods (2010) 0.83
Poly-L-lysine increases the ex vivo expansion and erythroid differentiation of human hematopoietic stem cells, as well as erythroid enucleation efficacy. Tissue Eng Part A (2014) 0.82
Down with the erythropoietin. Long live the erythropoietin! Curr Drug Targets (2009) 0.79
In vitro production of transfusable red blood cells. Biotechnol Genet Eng Rev (2008) 0.78
Red blood cells from pluripotent stem cells for use in transfusion. Regen Med (2010) 0.77